Credit Suisse Ag Evelo Biosciences, Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$0.17 - $1.57 $9,005 - $83,167
-52,973 Reduced 1.44%
3,625,415 $652,000
Q4 2022

Feb 13, 2023
BUY
$1.44 - $48.2 $11,822 - $395,722
8,210 Added 0.22%
3,678,388 $5.92 Million
Q3 2022

Nov 10, 2022
SELL
$1.86 - $41.8 $8,457 - $190,064
-4,547 Reduced 0.12%
3,670,178 $7.67 Million
Q2 2022

Aug 12, 2022
SELL
$1.46 - $3.55 $3,560 - $8,658
-2,439 Reduced 0.07%
3,674,725 $7.75 Million
Q1 2022

May 16, 2022
BUY
$2.66 - $6.63 $294,400 - $733,788
110,677 Added 3.1%
3,677,164 $12.5 Million
Q4 2021

Feb 14, 2022
BUY
$6.07 - $12.0 $1.55 Million - $3.07 Million
255,576 Added 7.72%
3,566,487 $21.6 Million
Q3 2021

Nov 12, 2021
BUY
$6.79 - $13.9 $1.46 Million - $2.99 Million
215,192 Added 6.95%
3,310,911 $23.3 Million
Q2 2021

Aug 16, 2021
BUY
$9.43 - $16.6 $1.01 Million - $1.78 Million
107,149 Added 3.59%
3,095,719 $42.5 Million
Q1 2021

May 14, 2021
BUY
$9.71 - $18.6 $2.75 Million - $5.26 Million
283,059 Added 10.46%
2,988,570 $32 Million
Q4 2020

Feb 12, 2021
BUY
$3.91 - $12.28 $766,852 - $2.41 Million
196,126 Added 7.82%
2,705,511 $32.7 Million
Q3 2020

Nov 13, 2020
BUY
$3.81 - $5.73 $1,725 - $2,595
453 Added 0.02%
2,509,385 $13.2 Million
Q2 2020

Aug 12, 2020
BUY
$3.53 - $6.12 $3.56 Million - $6.17 Million
1,008,815 Added 67.25%
2,508,932 $12.3 Million
Q1 2020

May 13, 2020
BUY
$3.21 - $7.06 $986,587 - $2.17 Million
307,348 Added 25.77%
1,500,117 $5.63 Million
Q4 2019

Feb 12, 2020
BUY
$3.81 - $7.45 $112,242 - $219,477
29,460 Added 2.53%
1,192,769 $4.84 Million
Q3 2019

Nov 12, 2019
BUY
$5.45 - $8.8 $332,646 - $537,116
61,036 Added 5.54%
1,163,309 $7.1 Million
Q2 2019

Aug 14, 2019
SELL
$6.52 - $9.42 $9,714 - $14,035
-1,490 Reduced 0.13%
1,102,273 $9.9 Million
Q1 2019

May 14, 2019
BUY
$7.5 - $15.31 $8,152 - $16,641
1,087 Added 0.1%
1,103,763 $8.83 Million
Q4 2018

Feb 13, 2019
BUY
$7.29 - $13.01 $1.56 Million - $2.79 Million
214,389 Added 24.14%
1,102,676 $14.3 Million
Q3 2018

Nov 13, 2018
BUY
$11.93 - $14.76 $5.35 Million - $6.61 Million
448,118 Added 101.81%
888,287 $10.8 Million
Q2 2018

Aug 14, 2018
BUY
$11.39 - $16.26 $5.01 Million - $7.16 Million
440,169 New
440,169 $5.19 Million

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email